Ðǿմ«Ã½

    Advertisement
    pharmaphorum11:38Mounjaro Eli Lilly Pharma
    Glasgow Evening Times17:02Mounjaro Eli Lilly Pharma
    Longevity Technology21:29Mounjaro Ozempic Global Health
    Kuwait Times15:41Mounjaro Ozempic Global Health
    Medpage Today09:22Mounjaro Health Crime
    Medpage Today15:34Mounjaro Health Crime
    The Korea Times00:04Mounjaro Novo Nordisk Ozempic
    Korea JoongAng Daily03:18Mounjaro Novo Nordisk Ozempic
    Pharmaceutical Technology07:28Mounjaro Eli Lilly Pharma
    Yahoo! UK & Ireland13:42Mounjaro Eli Lilly Pharma
    PharmaTimes03:45Mounjaro Eli Lilly Pharma
    Pharmacy Times15:46Mounjaro Eli Lilly Pharma
    FOX13 Seattle16:15Ozempic Health
    Fox News13:45Ozempic Health
    The Dallas Express16:02Mounjaro Ozempic Canada
    The Financial Express23:54Mounjaro Ozempic Canada
    ScienceAlert22:37Ozempic Global Health Health
    The Conversation (UK)16:18Ozempic Global Health Health
    pharmaphorum06:34Pharma Apple Top Tech Brands
    Yesterday
    The Dallas Express16:02 16-Aug-25
    In the last 7 days
    IBTimes.co.uk14:15 15-Aug-25
    Benzinga14:07 15-Aug-25
    Benzinga13:59 15-Aug-25
    MailOnline12:28 15-Aug-25
    Patient.info11:43 15-Aug-25
    Zacks10:30 15-Aug-25
    Zacks10:20 15-Aug-25
    Nature.com07:59 15-Aug-25
    Pharmaceutical Technology07:28 15-Aug-25
    LADbible06:41 15-Aug-25
    IBTimes.co.uk06:38 15-Aug-25
    My London05:50 15-Aug-25
    Pulse05:31 15-Aug-25
    Pharmaceutical Technology04:55 15-Aug-25
    Proactive Investors (UK)03:48 15-Aug-25
    Northern Kentucky Tribune00:43 15-Aug-25
    The Korea Times00:04 15-Aug-25
    Longevity Technology21:29 14-Aug-25
    Knowridge Science Report20:08 14-Aug-25
    British Medical Journal18:49 14-Aug-25
    Medpage Today18:37 14-Aug-25
    Glasgow Evening Times17:02 14-Aug-25
    Yahoo! UK & Ireland13:42 14-Aug-25
    Metro.co.uk11:39 14-Aug-25
    pharmaphorum11:38 14-Aug-25
    Benzinga11:32 14-Aug-25
    Evening Standard11:11 14-Aug-25
    News-Medical.Net10:27 14-Aug-25
    Cork Beo09:35 14-Aug-25
    PR Newswire (Press Release)09:01 14-Aug-25
    Pharmaceutical Field08:39 14-Aug-25
    MailOnline07:51 14-Aug-25
    Chemistry World Magazine05:17 14-Aug-25
    pharmaphorum05:12 14-Aug-25
    PharmaTimes03:45 14-Aug-25
    Korea Biomedical Review02:13 14-Aug-25
    The Irish Times00:34 14-Aug-25
    Medpage Today17:20 13-Aug-25
    FOX13 Seattle16:15 13-Aug-25
    Fox News13:45 13-Aug-25
    Pharmaceutical Technology11:55 13-Aug-25
    Zacks11:52 13-Aug-25
    Medpage Today09:22 13-Aug-25
    Knowridge Science Report06:39 13-Aug-25
    The Financial Express06:12 13-Aug-25
    The Hindu Business Line05:00 13-Aug-25
    Korea JoongAng Daily03:18 13-Aug-25
    The Financial Express23:54 12-Aug-25
    PR Newswire (Press Release)19:03 12-Aug-25
    Business Wire (Press Release)16:11 12-Aug-25
    Medpage Today15:34 12-Aug-25
    Community Impact Newspaper12:31 12-Aug-25
    Pulse07:19 12-Aug-25
    pharmaphorum06:34 12-Aug-25
    Knowridge Science Report05:53 12-Aug-25
    Birmingham Live04:30 12-Aug-25
    The Independent02:20 12-Aug-25
    News-Medical.Net23:55 11-Aug-25
    ScienceAlert22:37 11-Aug-25
    Korea Biomedical Review22:36 11-Aug-25
    MailOnline20:31 11-Aug-25
    Medpage Today17:42 11-Aug-25
    National Law Review16:28 11-Aug-25
    The Conversation (UK)16:18 11-Aug-25
    Kuwait Times15:41 11-Aug-25
    Pharmaceutical Technology12:40 11-Aug-25
    MailOnline11:52 11-Aug-25
    MailOnline09:30 11-Aug-25
    YourStory08:14 11-Aug-25
    PMLiVE07:16 11-Aug-25
    Scroll.in04:09 11-Aug-25
    Nursing in Practice03:54 11-Aug-25
    Fox News17:41 10-Aug-25
    The Kansas City Star12:24 10-Aug-25
    In the last month
    Rolling Stone09:04 9-Aug-25
    LADbible05:57 9-Aug-25
    BroBible16:20 8-Aug-25
    ScienceAlert15:02 8-Aug-25
    Pharmacy Times12:20 8-Aug-25
    Sunday Post11:29 8-Aug-25
    Knowridge Science Report07:08 8-Aug-25
    The Argus, Sussex06:14 8-Aug-25
    Northern Kentucky Tribune03:39 8-Aug-25
    Korea Biomedical Review01:21 8-Aug-25
    MorningStar.com00:27 8-Aug-25
    The Fresno Bee17:44 7-Aug-25
    Business Wire (Press Release)16:07 7-Aug-25
    Yahoo! UK & Ireland14:20 7-Aug-25
    The Conversation (UK)14:13 7-Aug-25
    Pharmaceutical Technology14:12 7-Aug-25
    Benzinga14:00 7-Aug-25
    Bellingham Herald13:55 7-Aug-25
    National Law Review13:09 7-Aug-25
    The Economic Times12:52 7-Aug-25
    LADbible12:51 7-Aug-25
    Zacks12:40 7-Aug-25
    Clinical Trials Arena12:34 7-Aug-25
    News-Medical.Net12:32 7-Aug-25
    WebProNews09:11 7-Aug-25
    pharmaphorum08:38 7-Aug-25
    Tyla06:32 7-Aug-25
    Glasgow Evening Times06:00 7-Aug-25
    MailOnline19:43 6-Aug-25
    People17:34 6-Aug-25
    Zacks13:25 6-Aug-25
    24/7 Wall St.11:46 6-Aug-25
    U.S. Customs and Border Protection (Press Release)11:03 6-Aug-25
    Pharmaceutical Technology08:41 6-Aug-25
    PR Newswire (Press Release)08:36 6-Aug-25
    pharmaphorum07:10 6-Aug-25
    Business Wire (Press Release)07:05 6-Aug-25
    Knowridge Science Report06:47 6-Aug-25
    EasternEye05:59 6-Aug-25
    LADbible04:47 6-Aug-25
    view more headlines
    16 Aug 16:02

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.